We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.
JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...
- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response findings - - ReSTART U.S. multi-center pivotal trial...
JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...
- The overview presentation will review some of the Company’s recent achievements, including highly promising interim results from the Company’s pancreatic cancer safety and feasibility trial as...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -9.12408759124 | 2.74 | 2.86 | 2.41 | 68932 | 2.54840047 | CS |
4 | -0.54 | -17.8217821782 | 3.03 | 3.03 | 2.41 | 42580 | 2.72629132 | CS |
12 | -0.86 | -25.671641791 | 3.35 | 3.35 | 2.41 | 31929 | 2.9040766 | CS |
26 | -0.92 | -26.9794721408 | 3.41 | 3.6499 | 2.41 | 34444 | 2.98294677 | CS |
52 | -0.51 | -17 | 3 | 4.8001 | 2.41 | 45993 | 3.46558503 | CS |
156 | -9.06 | -78.4415584416 | 11.55 | 20.65 | 2.41 | 112388 | 9.44792235 | CS |
260 | -9.06 | -78.4415584416 | 11.55 | 20.65 | 2.41 | 112388 | 9.44792235 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions